Genmab | GEN - Market Capitalization

Stock Price
1,831.00
Daily Change
-1.50 -0.08%
Monthly
-13.22%
Yearly
11.85%
Q1 Forecast
1,757.86

Genmab reported DKK116.71B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Almirall EUR 2.73B 442.82M Feb/2026
Amarin USD 341M 4M Sep/2025
Amgen USD 201.45B 25.2B Feb/2026
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Demant DKK 40.69B 5.32B Feb/2026
Exelixis USD 12.27B 523M Feb/2026
Fresenius Medical Care EUR 13.1B 1.17B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GN Store Nord DKK 13.76B 2.35B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Insmed USD 23.91B 13.21B Feb/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025